Clinical Trials › NCT06292923
RecruitingPhase 2
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
Sponsored by Tiziana Life Sciences LTD
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 54
Target enrollment
5
U.S. states
Nov 2023
Start date
Nov 2025
Expected completion
Interventions / Treatments
ForalumabPlacebo
Conditions studied
Secondary Progressive Multiple Sclerosis
Where this trial is running (7 sites)
Massachusetts2 sites
Boston · Worcester
New York2 sites
Buffalo · New York
Connecticut1 site
North Haven
Maryland1 site
Baltimore
Pennsylvania1 site
Philadelphia
Participating MS centers on MS Buddy (6)
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
Baltimore, MD
Weill Cornell MS Center
New York, NY
New York, NY
Thomas Jefferson University Comprehensive MS Center
Philadelphia, PA
Philadelphia, PA
UMass Memorial Medical Center MS Clinic
Worcester, MA
Worcester, MA
Jacobs MS Center for Treatment and Research
Buffalo, NY
Buffalo, NY
Brigham Multiple Sclerosis Center
Boston, MA
Boston, MA
MS centers in Massachusetts
Compare treatment centers near a trial site by center type, providers and trials.
View Massachusetts centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.